Phospholipids (Essentiale Forte P)
Indications
Nutritional support in the management of damaged liver (due to chronic liver disease, liver cirrhosis, fatty liver & intoxication by hepatotoxic substances).
What benefits are offered by Phospholipids (Essentiale Forte P)?
Regeneration of injured liver cells
Phospholipids (Essentiale Forte P) supports regeneration of injured liver cells owing to the essential phospholipids that are the active substance of the medicine.1
Reduction of symptoms caused by liver injury
The medicine relieves subjective sensations of discomfort such as pressure and distension in the right upper abdominal region. 1
What is the main active substance of Phospholipids (Essentiale Forte P)?
Formulation
Each hard gelatin capsule contains:
De-oiled enriched phospholipids from soya-beans …… 300 mg
PHARMACEUTICAL PARTICULARS
List of excipients: Ethanol 96%, hard fat, soya-bean oil (Ph. Eur.), hydrogenated castor oil, ethyl vanillin,
1-(4-methoxyphenyl) ethanone, alpha-tocopherol, gelatin, colouring agents E 171, 172, sodium laurylsulfate, purified water.
As observed in experimental conditions, Phospholipids (Essentiale Forte P):
- exerts a hepatoprotective effect in acute liver injury caused by alcohol, acetaminophen etc.
- inhibition of liver fibrosis was also observed.
The basic action of phospholipids is acceleration of regeneration and stabilisation of cell membranes, inhibition of lipid peroxidation and inhibition of collagen synthesis, which prevents liver fibrosis.1
Here are the most important facts which are worth knowing about phospholipids.
Uses and dosage 1
Capsules should be taken with meals, without chewing (e.g. with a glass of water).
Essentially, there are no limitations on the duration of use of Essentiale Forte, but the recommended duration of treatment should be at least 1-3 months.
Treatment duration may also be determined individually by the physician.
Adults
2 hard gelatin capsules three times a day
Children (12+)*
2 capsules three times daily
*12+ with a body weight of 43Kg or higher
Persons with allergies
The medicine should not be used by persons who are allergic to essential phospholipids, soybean or peanuts.
Pregnant and breast-feeding women
Due to lack of clinical data, the medicine should not be used by pregnant and breast-feeding women.
FAQ
-
Take Phospholipids (Essentiale Forte P) with meals, drinking a glass of water (never other beverages). 1
-
In accordance with the existing recommendations:
Phospholipids (Essentiale Forte P) is a medicine used in liver diseases.
It relieves subjective discomforts such as: lack of appetite, sensation of pressure in the right epigastric area due to liver injury caused by unhealthy diet, toxic substance effects or hepatitis.1 Essentially, there are no limitations on the duration of use of Phospholipids (Essentiale Forte P), but the recommended duration of treatment should be at least 1-3 months.1
-
As any other medicine, Phospholipids (Essentiale Forte P) may cause adverse drug reactions. An allergic reaction may occur, such as erythema, rash, urticaria, itching; gastrointestinal disturbances such as nausea, loose stools, diarrhea or abdominal discomfort (the frequency of these adverse drug reactions is unknown, cannot be estimated from the available data).
-
Take capsules with meals, without chewing (for example with a glass of water). 1
-
Store at temperatures not exceeding 30°C. Store in original package. Protect from moisture.
-
Phospholipids (Essentiale Forte P) should be taken only before its expiry date.1
The expiry date is stated on the pack.
-
In relation to the limited number of clinical trials of Phospholipids (Essentiale Forte P) in this patient group, pregnant women and breast-feeding women should not use this medicine.1
-
As any other medicine, Phospholipids (Essentiale Forte P) should not be taken while drinking alcohol.1
-
Phospholipids (Essentiale Forte P) is a gluten-free product.1
-
Phospholipids (Essentiale Forte P) is a vegan product.1
-
You may download it by clicking here.
Download
-
SmPC for Essentiale® Max approved in 04/2021. Date of first marketing authorisation: 21/12/2012.
-
SmPC for Essentiale® Forte approved in 04/2021. Date of first marketing authorisation: 10/07/1980.